ProShares Ultra Health Care (RXL)

NYSEARCA: RXL · Real-Time Price · USD
40.33
+0.77 (1.95%)
Sep 26, 2025, 4:00 PM EDT - Market closed
1.95%
Assets $62.89M
Expense Ratio 0.95%
PE Ratio n/a
Shares Out 1.59M
Dividend (ttm) $0.70
Dividend Yield 1.75%
Ex-Dividend Date Sep 24, 2025
Payout Ratio n/a
1-Year Return -26.61%
Volume 10,197
Open 39.90
Previous Close 39.56
Day's Range 39.89 - 40.39
52-Week Low 36.23
52-Week High 56.42
Beta 1.28
Holdings 67
Inception Date Jan 30, 2007

About RXL

Fund Home Page

The ProShares Ultra Health Care (RXL) is an exchange-traded fund that is based on the Health Care Select Sector index. The fund provides 2x leveraged exposure to a cap-weighted index of US health care companies. RXL was launched on Jan 30, 2007 and is issued by ProShares.

Asset Class Equity
Category Trading--Leveraged Equity
Region North America
Stock Exchange NYSEARCA
Ticker Symbol RXL
ETF Provider ProShares
Index Tracked Health Care Select Sector

Top 10 Holdings

147.43% of assets
Name Symbol Weight
HEALTH CARE SELECT SECTOR INDEX SWAP UBS AG n/a 26.74%
HEALTH CARE SELECT SECTOR INDEX SWAP GOLDMAN SACHS INTERNATIONAL n/a 22.61%
HEALTH CARE SELECT SECTOR INDEX SWAP BANK OF AMERICA NA n/a 20.18%
HEALTH CARE SELECT SECTOR INDEX SWAP SOCIETE GENERALE n/a 18.25%
HEALTH CARE SELECT SECTOR INDEX SWAP CITIBANK NA n/a 16.66%
HEALTH CARE SELECT SECTOR INDEX SWAP BNP PARIBAS n/a 15.09%
Eli Lilly and Company LLY 9.40%
Johnson & Johnson JNJ 7.06%
AbbVie Inc. ABBV 6.36%
UnitedHealth Group Incorporated UNH 5.08%
View More Holdings

Dividends

Ex-Dividend Amount Pay Date
Sep 24, 2025 $0.20313 Sep 30, 2025
Jun 25, 2025 $0.21928 Jul 1, 2025
Mar 26, 2025 $0.13435 Apr 1, 2025
Dec 23, 2024 $0.14718 Dec 31, 2024
Sep 25, 2024 $0.12875 Oct 2, 2024
Jun 26, 2024 $0.17268 Jul 3, 2024
Full Dividend History

News

ProShares and ProFunds Announce Benchmark Changes for 53 Geared Sector Funds

BETHESDA, Md.--(BUSINESS WIRE)--ProShares and ProFunds, premier providers of leveraged and inverse funds, announced plans to change the underlying indices for a combined 53 sector ETFs and mutual fu...

Other symbols: DIGDUGLTLREKREWROMRXD
2 years ago - Business Wire

Biotech Innovations Remain At Forefront

The first quarter of 2021 was challenging for the biotechnology industry, as the selloff in March represented a sharp reversal from record highs in February. While the sector has remained relatively r...

4 years ago - Seeking Alpha

Healthcare: A Wide Choice Of Large And Well-Established Companies

The advantage for dividend investors in this sector is the wide choice of large and well-established companies. AbbVie is a drug company with strong exposure to the immunology and the oncology markets...

5 years ago - Seeking Alpha

RXL Is The Best Healthcare ETF Wealth-Builder Now

RXL Is The Best Healthcare ETF Wealth-Builder Now

5 years ago - Seeking Alpha